Dengue vaccine starting next week at Spallanzani - last minute. Visit and vaccination are at the user's expense.
Last September, AIFA gave the green light to the single vaccine for the prevention of the disease approved in Italy, even for those who have not had previous exposure to the virus. The vaccine produced by Takeda is tetravalent, live attenuated, for prophylaxis against dengue disease. It can be administered to subjects from 4 years of age and 2 doses are sufficient to achieve immunization.